Abstract
The current challenge for evidence-based policy making (EBPM) held in the Japanese government lacks clear definition and scope of application in itself. By reconsidering the practice of evidence-based medicine (EBM) as a source of EBPM, and comparing between the two ideas, the author indicates that EBPM shall not correspond to clinical practice on each individual patient, but to the research process in EBM, as to design and practice clinical trials, evaluate them to establish treatment guidelines which shall be respected prima facie in the medical practices. From this viewpoint, the author tried to lead some lesson against the Japanese EBPM practice on its limits and standards in evaluation, as to be unassertive in making policy to have wide and unpredictable influence over human rights, to incorporate cancellation conditions on policies to realize suppression effects, and to respect comparative legal studies.
